digital health companies glp-1 management private obesity GLP-1 Drugs, Digital Health & Obesity Trends in 2026-kerentamir.com Use of GLP - 1

PlexusDx explains what you need to know about combining ibuprofen with GLP-1 therapy and offers evidence-based alternatives for safe pain relief

We explain the latest on oral GLP-1s, upcoming releases, and how they compare to injections for weight loss.

While GLP-1 receptor agonists dominate modern weight management, other medication classes offer distinct mechanisms for addressing obesity

GLP-1 agonists for alcohol use disorder: explore emerging research on semaglutide and similar medications, their potential mechanisms in reducing alcohol consumption, current UK guidance, safety considerations, and why they remain unlicensed for this use.

Dulaglutide is a once-weekly injectable glucagon-like peptide-1 (GLP-1) receptor agonist that has shown a durable glycemic efficacy as well as beneficial effects on body weight andmajor adverse cardiovascular events (MACE) outcomes, making it an important option for the treatment of type 2 diabetes